Cavium, Inc. (CAVM) Expected to Post Quarterly Sales of $238.92 Million

Wall Street analysts expect that Cavium, Inc. (NASDAQ:CAVM) will announce sales of $238.92 million for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Cavium’s earnings, with the lowest sales estimate coming in at $238.18 million and the highest estimate coming in at $239.33 million. Cavium reported sales of $107.16 million in the same quarter last year, which would suggest a positive year over year growth rate of 123%. The company is expected to issue its next quarterly earnings results on Tuesday, July 25th.

On average, analysts expect that Cavium will report full year sales of $238.92 million for the current fiscal year, with estimates ranging from $967.61 million to $978.66 million. For the next year, analysts anticipate that the company will post sales of $1.09 billion per share, with estimates ranging from $1.07 billion to $1.13 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that cover Cavium.

Cavium (NASDAQ:CAVM) last issued its quarterly earnings data on Wednesday, April 26th. The semiconductor provider reported $0.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.29 by $0.09. The firm had revenue of $229.58 million for the quarter, compared to analysts’ expectations of $227.22 million. Cavium had a positive return on equity of 4.05% and a negative net margin of 26.52%. The business’s revenue for the quarter was up 125.3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.25 EPS.

CAVM has been the subject of several research analyst reports. Needham & Company LLC reissued a “buy” rating and issued a $77.00 target price on shares of Cavium in a research report on Monday, February 27th. Bank of America Corporation reissued a “buy” rating on shares of Cavium in a research report on Thursday, March 2nd. Barclays PLC boosted their target price on shares of Cavium from $70.00 to $80.00 and gave the stock an “overweight” rating in a research report on Monday, March 6th. Argus boosted their target price on shares of Cavium from $75.00 to $82.00 and gave the stock a “buy” rating in a research report on Tuesday, March 14th. Finally, Macquarie initiated coverage on shares of Cavium in a research report on Thursday, March 30th. They issued an “outperform” rating and a $85.00 target price for the company. Eight research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Cavium presently has an average rating of “Buy” and a consensus price target of $72.79.

Shares of Cavium (CAVM) traded down 0.06% during trading on Thursday, hitting $66.75. The company’s stock had a trading volume of 7,343,221 shares. The firm’s 50 day moving average price is $71.07 and its 200-day moving average price is $67.88. Cavium has a 52 week low of $35.90 and a 52 week high of $76.26. The company’s market cap is $4.53 billion.

In other Cavium news, SVP Vincent P. Pangrazio sold 15,000 shares of the company’s stock in a transaction dated Tuesday, May 16th. The shares were sold at an average price of $75.73, for a total value of $1,135,950.00. Following the completion of the transaction, the senior vice president now owns 60,039 shares in the company, valued at approximately $4,546,753.47. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP Arthur D. Chadwick sold 40,000 shares of the company’s stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $75.14, for a total transaction of $3,005,600.00. Following the completion of the transaction, the vice president now owns 75,383 shares of the company’s stock, valued at approximately $5,664,278.62. The disclosure for this sale can be found here. 4.65% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of CAVM. IFP Advisors Inc boosted its position in Cavium by 6.9% in the first quarter. IFP Advisors Inc now owns 1,559 shares of the semiconductor provider’s stock valued at $112,000 after buying an additional 101 shares during the period. Solaris Asset Management LLC boosted its position in Cavium by 52.4% in the first quarter. Solaris Asset Management LLC now owns 1,600 shares of the semiconductor provider’s stock valued at $115,000 after buying an additional 550 shares during the period. US Bancorp DE boosted its position in Cavium by 85.1% in the first quarter. US Bancorp DE now owns 1,888 shares of the semiconductor provider’s stock valued at $135,000 after buying an additional 868 shares during the period. Bluestein R H & Co. purchased a new position in Cavium during the first quarter valued at approximately $215,000. Finally, FNY Partners Fund LP boosted its position in Cavium by 1.2% in the first quarter. FNY Partners Fund LP now owns 3,400 shares of the semiconductor provider’s stock valued at $243,000 after buying an additional 40 shares during the period.

WARNING: “Cavium, Inc. (CAVM) Expected to Post Quarterly Sales of $238.92 Million” was posted by sleekmoney and is the property of of sleekmoney. If you are reading this report on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://sleekmoney.com/cavium-inc-cavm-expected-to-post-quarterly-sales-of-238-92-million/1939023.html.

About Cavium

Cavium, Inc is a provider of integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage and security applications. The Company’s products consist of multi-core processors for embedded and data center applications, network connectivity for server and switches, storage connectivity, and security processors for offload and appliance.

Get a free copy of the Zacks research report on Cavium (CAVM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/cavium-inc-cavm-expected-to-post-quarterly-sales-of-238-92-million/1939023.html

Receive News & Ratings for Cavium Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *